|
Study and author | Disease model | Tissue element captured | Type of epigenetic modification studied |
|
Singh et al. [42] | Diabetes | CD31+ endothelial element | Methylation of miR-200b promoter |
Ren et al. [8] | Ovarian cancer | Tissue from ovarian carcinoma | Inactivation of hMLH1 during malignancy |
Li et al. [9] | Aging | Dermal and epidermal elements | Expression of PTGES1 and COX2 mRNA expression |
Wu et al. [36] | Endometriosis | Epithelial component of endometriotic implants | Methylation status of progesterone receptors (PRA, PRB) |
Greenspan et al. [2] | Colon tumorigenesis | Colonic epithelial elements | Methylation status of RASSF1A |
Sigalotti et al. [39] | Melanoma | Cutaneous melanoma cellular elements | Methylation of LINE-1 |
Nie et al. [41] | Chronic wounds | Diabetic ulcers | miRNA expression of NFkB, TGF-B/SMED |
Singh et al. [43] | Wound angiogenesis | Human dermal microvascular endothelial cells | E-Cadherin/ZEB1 expression |
Wu et al. [53] | Cutaneous T cell lymphoma | Human CTCL lines HH, Sz4, MyLa, Hut 78 | CpG methylation of FAS/CD95 |
Masterson et al. [54] | Merkel cell carcinoma | Tumor resection epithelial elements | Expression of KRT20, KIF3A, and MUCI1 |
|